Integrated community-based HIV and non-communicable disease care within microfinance groups in Kenya: study protocol for the Harambee cluster randomised trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 05 2021
Historique:
entrez: 19 5 2021
pubmed: 20 5 2021
medline: 4 6 2021
Statut: epublish

Résumé

In Kenya, distance to health facilities, inefficient vertical care delivery and limited financial means are barriers to retention in HIV care. Furthermore, the increasing burden of non-communicable diseases (NCDs) among people living with HIV complicates chronic disease treatment and strains traditional care delivery models. Potential strategies for improving HIV/NCD treatment outcomes are differentiated care, community-based care and microfinance (MF). We will use a cluster randomised trial to evaluate integrated community-based (ICB) care incorporated into MF groups in medium and high HIV prevalence areas in western Kenya. We will conduct baseline assessments with n=900 HIV positive members of 40 existing MF groups. Group clusters will be randomised to receive either (1) ICB or (2) standard of care (SOC). The ICB intervention will include: (1) clinical care visits during MF group meetings inclusive of medical consultations, NCD management, distribution of antiretroviral therapy (ART) and NCD medications, and point-of-care laboratory testing; (2) peer support for ART adherence and (3) facility referrals as needed. MF groups randomised to SOC will receive regularly scheduled care at a health facility. Findings from the two trial arms will be compared with follow-up data from n=300 matched controls. The primary outcome will be VS at 18 months. Secondary outcomes will be retention in care, absolute mean change in systolic blood pressure and absolute mean change in HbA1c level at 18 months. We will use mediation analysis to evaluate mechanisms through which MF and ICB care impact outcomes and analyse incremental cost-effectiveness of the intervention in terms of cost per HIV suppressed person-time, cost per patient retained in care and cost per disability-adjusted life-year saved. The Moi University Institutional Research and Ethics Committee approved this study (IREC#0003054). We will share data via the Brown University Digital Repository and disseminate findings via publication. NCT04417127.

Identifiants

pubmed: 34006540
pii: bmjopen-2020-042662
doi: 10.1136/bmjopen-2020-042662
pmc: PMC8137246
doi:

Banques de données

ClinicalTrials.gov
['NCT04417127']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e042662

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118075
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S40-53
pubmed: 25117960
J Gen Intern Med. 2009 Feb;24(2):189-97
pubmed: 19031037
PLoS One. 2016 Oct 20;11(10):e0164634
pubmed: 27764128
BMC Public Health. 2016 Aug 08;16:741
pubmed: 27503191
Trop Med Int Health. 2014 Dec;19(12):1397-410
pubmed: 25227621
Qual Life Res. 1997 Aug;6(6):481-93
pubmed: 9330549
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Salud Publica Mex. 2011;53 Suppl 4:425-35
pubmed: 22282205
Glob Heart. 2015 Dec;10(4):313-7
pubmed: 26704963
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21654
pubmed: 28770590
AIDS Behav. 2016 May;20(5):973-6
pubmed: 26563760
BMC Public Health. 2018 Nov 7;18(Suppl 3):1219
pubmed: 30400858
BMC Psychol. 2018 Jul 17;6(1):31
pubmed: 30016997
Value Health. 2015 Mar;18(2):161-72
pubmed: 25773551
BMC Endocr Disord. 2018 Dec 27;18(1):97
pubmed: 30591044
Global Health. 2018 May 8;14(1):44
pubmed: 29739421
J Health Econ. 2009 Jan;28(1):20-34
pubmed: 18824268
Bull World Health Organ. 2009 Jul;87(7):512-9
pubmed: 19649365
AIDS Care. 2011 Sep;23(9):1177-85
pubmed: 21500024
Eur J Health Econ. 2010 Oct;11(5):437-47
pubmed: 19756796
AIDS Behav. 2018 Nov;22(11):3726-3733
pubmed: 29079947
AIDS Behav. 2019 Sep;23(9):2238-2252
pubmed: 30805757
AIDS Res Treat. 2013;2013:485715
pubmed: 23738055
PLoS Med. 2007 Oct 16;4(10):e298
pubmed: 17941716
AIDS. 2016 Jan 28;30(3):495-502
pubmed: 26765940
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e46-55
pubmed: 25692336
BMJ Open. 2016 Aug 23;6(8):e011921
pubmed: 27554104
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):e16-23
pubmed: 26473798
Am Heart J. 2017 Jun;188:175-185
pubmed: 28577673
J Health Soc Behav. 1995 Mar;36(1):1-10
pubmed: 7738325
AIDS Patient Care STDS. 2013 Aug;27(8):481-8
pubmed: 23968206
Annu Rev Public Health. 2016;37:17-32
pubmed: 26653405
J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):399-406
pubmed: 31658183
Ann Pharmacother. 2011 Jun;45(6):721-6
pubmed: 21558485
Trop Med Int Health. 2015 Oct;20(10):1265-70
pubmed: 25962952
Biometrika. 2016 Jun;103(2):483-490
pubmed: 27279672
BMC Health Serv Res. 2017 Jul 3;17(1):454
pubmed: 28673344
HIV AIDS (Auckl). 2013;5:1-17
pubmed: 23326204
Health Policy Plan. 2012 Mar;27(2):85-101
pubmed: 21343235
WHO South East Asia J Public Health. 2014 Jun 30;3(2):125-134
pubmed: 25685728
J Acquir Immune Defic Syndr. 2015 May 1;69(1):98-108
pubmed: 25942461
Soc Sci Med. 2015 May;132:30-7
pubmed: 25792337
Health Serv Res. 1998 Aug;33(3 Pt 1):571-96
pubmed: 9685123
Health Serv Res. 2016 Aug;51(4):1323-46
pubmed: 27417264
BMC Health Serv Res. 2014 Dec 19;14:646
pubmed: 25523349
BMC Public Health. 2018 Nov 7;18(Suppl 3):1215
pubmed: 30400865
BMC Health Serv Res. 2015 Nov 17;15:512
pubmed: 26577953
AIDS. 2016 Sep 10;30(14):2145-8
pubmed: 27367489
AIDS. 2015 Sep 10;29(14):1889-94
pubmed: 26214684
PLoS One. 2016 Aug 10;11(8):e0159994
pubmed: 27509182
PLoS One. 2013;8(2):e56088
pubmed: 23418518
J Gen Intern Med. 2017 May;32(5):540-548
pubmed: 27921256
PLoS Med. 2017 Nov 7;14(11):e1002421
pubmed: 29112691
Dig Dis Sci. 2019 Oct;64(10):2784-2797
pubmed: 31037593
Qual Life Res. 2012 Nov;21(9):1655-63
pubmed: 22198741
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
AIDS Care. 2015;27(7):817-28
pubmed: 25671515
Acad Med. 2007 Aug;82(8):812-8
pubmed: 17762264

Auteurs

Becky L Genberg (BL)

Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Juddy Wachira (J)

Behavioral Sciences, Moi University College of Health Sciences, School of Medicine, Eldoret, Kenya.

Jon A Steingrimsson (JA)

Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.

Sonak Pastakia (S)

Center for Health Equity and Innovation, Purdue University College of Pharmacy, Indianapolis, Indiana, USA.
Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Dan N Tina Tran (DNT)

Center for Health Equity and Innovation, Purdue University College of Pharmacy, Indianapolis, Indiana, USA.
Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Jamil AbdulKadir Said (JA)

Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Internal Medicine, Moi University School of Medicine, Eldoret, Kenya.

Paula Braitstein (P)

Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Epidemiology, University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.

Joseph W Hogan (JW)

Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.
Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Rajesh Vedanthan (R)

Global Health, New York University Grossman School of Medicine, New York, New York, USA.

Suzanne Goodrich (S)

Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Catherine Kafu (C)

Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Marta Wilson-Barthes (M)

Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

Omar Galárraga (O)

Health Services, Policy and Practice, Brown University School of Public Health, 121 South Main St. Box G-S121-2 Providence, Rhode Island, USA omar_galarraga@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH